Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$0.19 - $0.45 $817 - $1,935
-4,300 Reduced 0.65%
656,111 $153,000
Q1 2022

May 13, 2022

SELL
$0.36 - $0.77 $2,622 - $5,610
-7,286 Reduced 1.09%
660,411 $258,000
Q4 2021

Feb 17, 2022

SELL
$0.69 - $1.73 $25,978 - $65,134
-37,650 Reduced 5.34%
667,697 $462,000
Q3 2021

Oct 29, 2021

SELL
$1.38 - $2.15 $126 - $197
-92 Reduced 0.01%
705,347 $1.22 Million
Q2 2021

Jul 22, 2021

BUY
$1.98 - $2.74 $1.4 Million - $1.93 Million
705,439 New
705,439 $1.54 Million

About ENDRA Life Sciences Inc.


  • Ticker NDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 63,174,500
  • Market Cap $353M
  • Description
  • ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...
More about NDRA
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.